Katen Patel
Direttore/Membro del Consiglio presso NFlection Therapeutics, Inc.
Provenienza dei contatti di primo grado di Katen Patel
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
NFlection Therapeutics, Inc.
NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA.
6
| Holding Company | Biotechnology | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Katen Patel tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Pharmaceuticals: Major | General Counsel | |
CERUS CORPORATION | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Investment Banks/Brokers | Corporate Officer/Principal | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Public Communications Contact | |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Founder | |
ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
PellePharm, Inc.
PellePharm, Inc. BiotechnologyHealth Technology PellePharm, Inc. engages in the operation of a biotechnology company committed to targeting rare dermatologic diseases. It develops Patidegib , an investigational topical treatment designed to mitigate the tumor burden in patients with Gorlin Syndrome and Basal Cell Carcinomas (BCCs), and other potential indications. The firm also focuses on commercializing Patidegib treatment by potentially reducing invasive and painful surgeries. The company was founded by Michael Henderson, Jean Tang, Ervin Epstein, and Philip Beachy and is headquartered in San Francisco, CA. | Biotechnology | Chief Operating Officer | |
Vapogenix, Inc.
Vapogenix, Inc. Medical/Nursing ServicesHealth Services Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX. | Medical/Nursing Services | Chief Executive Officer | |
FIBROGEN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Yale University | College/University | Undergraduate Degree | |
Oakland University (Michigan) | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Doctorate Degree | |
California Polytechnic State University (San Luis Obispo) | College/University | Undergraduate Degree | |
The State University of New York | College/University | Undergraduate Degree | |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Miscellaneous Commercial Services | Director/Board Member | |
Promedior, Inc.
Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal | |
PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Harvard Medical School | College/University | Graduate Degree | |
Vrolyk & Co. | Corporate Officer/Principal | ||
Wyeth Laboratories, Inc. | Corporate Officer/Principal | ||
The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
University of Rochester Simon Business School | College/University | Masters Business Admin | |
Meves Pharmaceuticals, Inc.
Meves Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meves Pharmaceuticals, Inc. provides pharmaceutical products and services. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Chief Executive Officer | |
Modis Therapeutics, Inc.
Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modis Therapeutics, Inc. is a biopharmaceutical company, which develops disease-modifying therapies for rare genetic diseases. Its product MT1621 is in clinical development for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease. The company was founded by Peter H. Barber and Daniel D. DiPietro in 2016 and is headquartered in Oakland, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Alexo Therapeutics International
Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chairman | |
3CC Management LLC
3CC Management LLC Investment ManagersFinance 3CC Management LLC (Third Culture Capital) is a venture capital firm founded in 2020 by Julien L. Pham. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Mindrythm
Mindrythm Medical SpecialtiesHealth Technology Mindrythm is a brain wellness company based in San Francisco, CA. Mindrythm develops medical technology to prevent neurological injury, with a focus on stroke prevention. The company's proprietary monitoring devices and communication platform aim to solve the triage problem in stroke, potentially saving more than 200,000 lives in 2022. The company was founded by John Keane and Paul Lovoi, with John Keane serving as the CEO since incorporation. | Medical Specialties | Chairman |
Statistiche
Distribuzione geografica
Stati Uniti | 35 |
Settori
Health Technology | 18 |
Consumer Services | 9 |
Finance | 4 |
Commercial Services | 3 |
Health Services | 2 |
Posizioni
Corporate Officer/Principal | 11 |
Director/Board Member | 9 |
Chief Executive Officer | 7 |
Undergraduate Degree | 4 |
Chief Operating Officer | 4 |
Contatti più connessi
Insiders | |
---|---|
Joshua Grass | 10 |
William Hodder | 9 |
Christopher Powala | 7 |
Gerd Kochendoerfer | 6 |
Kenneth Tsai | 6 |
Corey Goodman | 3 |
- Borsa valori
- Insiders
- Katen Patel
- Connessioni Società